Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

PCN Insights, News, Videos, and More

News
03/22/2021
The COVID-19 pandemic has resulted in dramatic changes to sleep patterns at a time when the health benefits from quality sleep are especially important, researcher and sleep expert Charles M. Morin, PhD, said at a virtual symposium.
The COVID-19 pandemic has resulted in dramatic changes to sleep patterns at a time when the health benefits from quality sleep are especially important, researcher and sleep expert Charles M. Morin, PhD, said at a virtual symposium.
The COVID-19 pandemic has...
03/22/2021
Psych Congress Network
Rakesh Jain, MD, MPH, on Emergence of Psychedelic Therapies: What Clinicians Need to Know
Videos
03/22/2021
Sana Symposium steering committee member Rakesh Jain, MD, MPH, clinical professor in the Department of Psychiatry at the Texas Tech University Health Sciences Center School of Medicine and co-investigator for Psychedelics and Wellness...
Sana Symposium steering committee member Rakesh Jain, MD, MPH, clinical professor in the Department of Psychiatry at the Texas Tech University Health Sciences Center School of Medicine and co-investigator for Psychedelics and Wellness...
Sana Symposium steering...
03/22/2021
Psych Congress Network
News
03/19/2021
Setting clear and attainable goals, praising genuine efforts, and allowing failure are key in supporting children’s virtual learning efforts during the pandemic, according to a session presented at the Anxiety and Depression Association of...
Setting clear and attainable goals, praising genuine efforts, and allowing failure are key in supporting children’s virtual learning efforts during the pandemic, according to a session presented at the Anxiety and Depression Association of...
Setting clear and attainable...
03/19/2021
Psych Congress Network
News
03/19/2021
Confirming results from a previous smaller study, researchers found people who reported a history of childhood maltreatment had a more robust response to intravenous (IV) ketamine than other depressed adults seeking ketamine treatment.
Confirming results from a previous smaller study, researchers found people who reported a history of childhood maltreatment had a more robust response to intravenous (IV) ketamine than other depressed adults seeking ketamine treatment.
Confirming results from a...
03/19/2021
Psych Congress Network
News
03/19/2021
More than half of 3904 US adults with previous COVID-19 illness met criteria for moderate or greater symptoms of major depressive disorder months later, according to a study published online in a research letter in JAMA Network Open.
More than half of 3904 US adults with previous COVID-19 illness met criteria for moderate or greater symptoms of major depressive disorder months later, according to a study published online in a research letter in JAMA Network Open.
More than half of 3904 US adults...
03/19/2021
Psych Congress Network
News
03/18/2021
Adults aged 65 years or older who had clinically significant fatigue at baseline had greater improvements in the Fatigue Severity Scale total score and all sleep parameters 6 months later, compared with placebo, a post hoc analysis of a phase...
Adults aged 65 years or older who had clinically significant fatigue at baseline had greater improvements in the Fatigue Severity Scale total score and all sleep parameters 6 months later, compared with placebo, a post hoc analysis of a phase...
Adults aged 65 years or older...
03/18/2021
Psych Congress Network
News
03/18/2021
Rather than compromise mental health, quitting smoking for at least 6 weeks can reduce anxiety, depression, and stress and improve mental well-being, according to an evidence review published in the Cochrane Database of Systematic...
Rather than compromise mental health, quitting smoking for at least 6 weeks can reduce anxiety, depression, and stress and improve mental well-being, according to an evidence review published in the Cochrane Database of Systematic...
Rather than compromise mental...
03/18/2021
Psych Congress Network
Developments in Treating Schizophrenia: New Mechanisms of Action and Methods of Delivery
Podcasts
03/18/2021
In this podcast, Schizophrenia Section Editor Leslie Citrome, MD, MPH, reviews recent developments and possible upcoming advances in the treatment of schizophrenia, including new mechanisms of action and methods of delivering medicine.
In this podcast, Schizophrenia Section Editor Leslie Citrome, MD, MPH, reviews recent developments and possible upcoming advances in the treatment of schizophrenia, including new mechanisms of action and methods of delivering medicine.
In this podcast, Schizophrenia...
03/18/2021
Psych Congress Network
News
03/17/2021
The prevalence of dementia in the United States is projected to triple in approximately the next 20 years, but there are several modifiable risk factors that could reduce the likelihood of developing the disease, Kristine Yaffe, MD, said in a...
The prevalence of dementia in the United States is projected to triple in approximately the next 20 years, but there are several modifiable risk factors that could reduce the likelihood of developing the disease, Kristine Yaffe, MD, said in a...
The prevalence of dementia in...
03/17/2021
Psych Congress Network
News
03/17/2021
Sage Therapeutics has released complete data from a 12-month study of patients taking 30 mg of the investigational oral neuroactive steroid zuranolone for major depressive disorder (MDD) and interim data on a cohort receiving a 50 mg dose.
Sage Therapeutics has released complete data from a 12-month study of patients taking 30 mg of the investigational oral neuroactive steroid zuranolone for major depressive disorder (MDD) and interim data on a cohort receiving a 50 mg dose.
Sage Therapeutics has released...
03/17/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement